BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SVACS - ECPv6.15.1.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.siliconvalleyacs.org
X-WR-CALDESC:Events for SVACS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221005T110000
DTEND;TZID=America/Los_Angeles:20221005T120000
DTSTAMP:20260425T115354
CREATED:20221003T232712Z
LAST-MODIFIED:20221003T232712Z
UID:19151-1664967600-1664971200@www.siliconvalleyacs.org
SUMMARY:Molecular Glues in Drug Discovery: Solutions that Stick for the Undruggable
DESCRIPTION:Philip Chamberlain\, Co-Founder\, President\, and CEO of Neomorph; Dr. Benjamin Ebert\, Chair\, Medical Oncology\, Dana-Farber Cancer Institute; Janet Sasso\, Information Scientist at CAS\nSponsored by ACS Webinars and CAS\n11am-Noon\, Online via Zoom\, Free\, Registration required\n\nMolecular glues have emerged as one of the promising approaches for drug discovery to treat a wide range of diseases such as cancer\, inflammatory and immune diseases\, and infections. Currently\, conventional small molecule inhibitors can only target a small portion of disease-causing proteins\, leaving the majority as undruggable. However\, protein degradation utilizing small molecule glues is able to recruit non-druggable proteins for rapid destruction. \n\n\n\nJoin Philip Chamberlain the Co-Founder\, President\, and CEO of Neomorph\, Dr. Benjamin Ebert\, the Chair of Medical Oncology of the Dana-Farber Cancer Institute\, and Janet Sasso\, Information Scientist at CAS as they discuss a landscape view of the research and drug discovery efforts for molecular glues\, the latest techniques for molecular glue drug discovery\, and their application in the treatment of diseases. \nThis ACS Webinar is moderated by Angela Zhou\, Information Scientist at CAS and is co-produced by CAS\, a division of the American Chemical Society. \n\n\n\n\n\n\nWhat You Will Learn\n\nLandscape views of molecular glue research\, drug discovery\, and therapeutic potential\nThe latest molecular glue drug discovery efforts\nApplication of molecular glues for disease treatment\n\n\n\n\n\n\n\nWebinar Details\n\nWednesday\, October 5\, 2022 @ 2-3pm ET\nFree to Register with ACS ID\nSlides will be available to download on the day of the webinar\n\n\n\n\n\n\n\nAdditional Resources\n\nMolecular Glues and Induced Proximity – Article by Janet Sasso of CAS\nMolecular Glues are Beginning to Stick – Article by Gina Vitale of C&EN
URL:https://www.siliconvalleyacs.org/event/molecular-glues-in-drug-discovery-solutions-that-stick-for-the-undruggable/
LOCATION:Virtual
CATEGORIES:ACS Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.siliconvalleyacs.org/wp-content/uploads/2022/10/Molecular-glues-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221006T110000
DTEND;TZID=America/Los_Angeles:20221006T121500
DTSTAMP:20260425T115354
CREATED:20221003T233325Z
LAST-MODIFIED:20221003T233325Z
UID:19154-1665054000-1665058500@www.siliconvalleyacs.org
SUMMARY:Navigating Questions About Reproductive Health When in the Lab
DESCRIPTION:Robin M. Izzo\, Asst VP\, Environmental Health and Safety\, Princeton University; Dr. Rich Wittman\, Clinical Assistant Professor of Medicine\, Stanford Health Care; Katie McGeough\, graduate student\, Boston College School of Social Work\nSponsored by ACS Webinars\, ACS Division of Chemical Health & Safety\, ACS Committee on Chemical Safety\n11am-Noon\, Online via Zoom\, Free\, Registration required\n\nA recent analysis of the current guidance from more than 100 academic institutions’ Chemical Hygiene Plans (CHPs) indicates that the burden to implement laboratory reproductive health and safety practices is often placed on those already pregnant or planning conception. This report also found inconsistencies in the classification of potential reproductive toxins by resources generally considered to be authoritative\, adding further confusion.
URL:https://www.siliconvalleyacs.org/event/navigating-questions-about-reproductive-health-when-in-the-lab/
LOCATION:Virtual
CATEGORIES:ACS Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.siliconvalleyacs.org/wp-content/uploads/2022/10/Navigating-questions-about-reproductive-health-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221013T110000
DTEND;TZID=America/Los_Angeles:20221013T120000
DTSTAMP:20260425T115354
CREATED:20221003T235844Z
LAST-MODIFIED:20221003T235844Z
UID:19166-1665658800-1665662400@www.siliconvalleyacs.org
SUMMARY:Debunking Publishing Myths: 10 Tips for Publishing in ACS Journals
DESCRIPTION:Editor-in-Chief Thomas Holme\, Journal of Chemical Education and Associate Editor Kelly Chibale\, Journal of Medicinal Chemistry\nSponsored by ACS Webinars\, ACS on Campus\, and ACS Publications\n11am-Noon\, Online via Zoom\, Free\, Registration required\n\nYou’ve done your research and now it’s time to prepare your manuscript\, choose a journal\, get published\, and attract a large readership. Sounds like a daunting process right? ACS Publications want to partner with authors to get their manuscript published as well as ensure authors have the best possible experience regardless of the decision made on their manuscript. \n\n\n\nJoin Editor-in-Chief Thomas Holme of the Journal of Chemical Education and Associate Editor Kelly Chibale of the Journal of Medicinal Chemistry as they provide you insider advice to make your manuscript clear\, concise\, and captivating so that you can improve your chances of getting publishing in an ACS Journal. \nThis ACS Webinar is moderated by Lorraine Clark of ACS Publications and Becky Miller of ACS on Campus and is co-produced with ACS on Campus and ACS Publications. \n\n\n\n\n\n\nWhat You Will Learn\n\nTen scholarly publishing tips to write a successful manuscript and choose the most appropriate journal\nHow to best understand the scope of a journal and its simplified submission requirements\nReal-life examples from submissions and some of the typical reasons for manuscript rejection\n\n\n\n\n\n\n\nWebinar Details\n\nThursday\, October 13\, 2022 @ 2-3pm ET\nFree to Register with ACS ID\nSlides will be available to download on the day of the webinar\n\n\n\n\n\n\n\nACS Resources To Enhance Your Research\n\nACS Author Lab is a free online course that empowers authors to prepare and submit strong manuscripts\, avoiding errors that could lead to delays in the publication process\nACS Authoring Services connects you with our language editors and scientific illustrators to help showcase your science at its best\nACS Author University provides videos and articles from our editor community on tips for scientific writing\, securing funding\, rejection\, and much more\nACS Reviewer Lab is a free\, on-demand peer review training course that provides real-life guidance on how to navigate tricky ethical situations\, identify core criteria for evaluating manuscripts\, and write a first-rate review
URL:https://www.siliconvalleyacs.org/event/debunking-publishing-myths-10-tips-for-publishing-in-acs-journals/
LOCATION:Virtual
CATEGORIES:ACS Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.siliconvalleyacs.org/wp-content/uploads/2022/10/Debunking-publishing-myths.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221020T110000
DTEND;TZID=America/Los_Angeles:20221020T120000
DTSTAMP:20260425T115354
CREATED:20221004T003809Z
LAST-MODIFIED:20221004T193604Z
UID:19176-1666263600-1666267200@www.siliconvalleyacs.org
SUMMARY:Creating Psychedelic Analogs to Treat Neuropsychiatric Disease
DESCRIPTION:Prof. David Olson\, Department of Chemistry\, Department of Biochemistry & Molecular Medicine\, UC Davis\nSponsored by ACS Webinars\, ACS Publications\, ACS Division of Medicinal Chemistry\, and American Association of Pharmaceutical Scientists\n11am-Noon\, Online via Zoom\, Free\, Registration required\n\nWe are at an exciting moment in drug discovery due to the enormous potential of psychedelics and related plasticity-promoting neurotherapeutics to treat common\, but highly debilitating conditions such as schizophrenia\, bipolar disorder\, major depressive disorder\, and attention deficit hyperactivity disorder. \nJoin Associate Professor Dr. David Olson of UC Davis as he discusses how psychedelics and related molecules\, such as DMT\, LSD\, and MDMA\, rapidly promote the growth of cortical neurons\, providing a potential explanation for their long-lasting therapeutic effects after a single dose. Register now to discover about the development of chemical and molecular tools for studying the mechanisms of action of psychedelics as well as efforts to engineer non-hallucinogenic analogs of these compounds that produce similar sustained therapeutic behavioral effects after a single administration. \nThis ACS Webinar is moderated by Editor-in-Chief Dr. Christa Müller of ACS Pharmacology & Translational Science co-produced with the ACS Division of Medicinal Chemistry\, and ACS Publications. \n\n\n\nWhat You Will Learn\n\nMechanistic details about psychedelic-induced neuroplasticity\nThe development of a novel biosensor for assessing hallucinogenic potential\nThe development of non-hallucinogenic psychoplastogens\n\n\n\n\n\n\n\nWebinar Details\n\nThrusday\, October 20\, 2022 @ 2-3pm ET\nFree to Register with ACS ID\nSlides will be available to download on the day of the webinar
URL:https://www.siliconvalleyacs.org/event/creating-psychedelic-analogs-to-treat-neuropsychiatric-disease/
LOCATION:Virtual
CATEGORIES:ACS Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.siliconvalleyacs.org/wp-content/uploads/2022/10/Creating-psychedelic-analogs-ACS-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221027T110000
DTEND;TZID=America/Los_Angeles:20221027T120000
DTSTAMP:20260425T115354
CREATED:20221004T001212Z
LAST-MODIFIED:20221004T001212Z
UID:19171-1666868400-1666872000@www.siliconvalleyacs.org
SUMMARY:Addressing Sustainability Challenges with Earth Abundant Metal Catalysis
DESCRIPTION:Paul Chirik\, Edward S. Sanford Professor\, Princeton University and Editor-in-Chief\, Organometallics\nSponsored by ACS Webinars\, ACS Office of Sustainable Development\, Organometallics\n11am-Noon\, Online via Zoom\, Free\, Registration required\n\nHow chemists interact with and ultimately use the elements on the periodic table is one of the primary sustainability challenges for the 21st century. Applications ranging from alternative energy to the synthesis of pharmaceuticals and every day products should rely on terrestrially abundant elements such as iron rather than rare ones that have a large environmental footprint associated with mining and purification. \nJoin Paul Chirik\, Edward S. Sanford Professor at Princeton University and Editor-in-Chief of Organometallics as he explores the new chemistry enabled by catalysis with Earth abundant transition metals. Dr. Chirik and his research group strive to discover highly effective catalysts with applications in the pharmaceutical\, flavor and fragrance\, silicones\, energy and polymer science industries and often engage with industrial collaborators. They seek to uncover the unique pathways that enable these transformations\, many of which are distinct from precious metals and rely on the unique electronic structures of the first row transition metals. Register now to discover the distinct chemistry enabled by iron and cobalt catalysts and the design principles that were used in catalyst discovery. Learn about real-life applications and broad challenges that confront the field such as air-stable\, easily handled precursors\, functional group tolerance\, ligand design and understanding reaction mechanism. \nThis ACS Webinar is moderated by Director of Sustainable Development\, Adelina Voutchkova-Kostal of ACS and is co-produced with the ACS Office of Sustainable Development and Organometallics. \nDiscover more about the webinar topic including submission details for the planned joint Virtual Special Issue in Organometallics and OPR&D “Advances and Applications in Catalysis with Earth-Abundant Metals.” \n\n\n\nWhat You Will Learn\n\nHow to understand your elemental footprint and what is the importance of elemental usage in society\nWhat is the indefensible role of hydrocarbons in our daily lives and what are some approaches to increase the sustainability of our elemental usage and hydrocarbon future\nWhat are the potential frontiers in development of sustainable base-metal catalytic transformations\n\n\n\n\n\n\n\nWebinar Details\n\nThursday\, October 27\, 2022 @ 2-3pm ET\nFree to Register with ACS ID\nSlides will be available to download on the day of the webinar
URL:https://www.siliconvalleyacs.org/event/addressing-sustainability-challenges-with-earth-abundant-metal-catalysis-2/
LOCATION:Virtual
CATEGORIES:ACS Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.siliconvalleyacs.org/wp-content/uploads/2022/10/Addressing-sustainability-challenges-ACS-webinar.jpg
END:VEVENT
END:VCALENDAR